STOCK TITAN

PTC Therapeutics to Participate at Upcoming Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) announced its participation in William Blair's 44th Annual Growth Stock Conference on June 4, 2024, at 9:00 am ET / 8:00 am CT. The presentation will be webcast live and accessible through the Investor section of PTC Therapeutics' website. The webcast will be archived for 30 days. Attendees should join early to ensure a timely connection.

Positive
  • Participation in a high-profile investor conference can enhance visibility and attract potential investors.
  • Webcast availability provides broader access to stakeholders unable to attend in person.
  • Archiving the presentation for 30 days allows extended access to information.
Negative
  • No new financial or clinical data updates were provided in the announcement.
  • Conference participation alone does not guarantee increased investor interest or stock performance.

WARREN, N.J., May 29, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conference:

William Blair's 44th Annual Growth Stock Conference
Tuesday, June 4, at 9:00 am ET / 8:00 am CT

The presentation will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
 Kylie O'Keefe
 +1 (908) 300-0691
 kokeefe@ptcbio.com

Media:
 Jeanine Clemente
 +1 (908) 912-9406
 jclemente@ptcbio.com

Cision View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conference-302157009.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics present at the William Blair Growth Stock Conference?

PTC Therapeutics will present on June 4, 2024, at 9:00 am ET / 8:00 am CT.

How can I watch the PTC Therapeutics investor presentation?

The presentation will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website.

Will the PTC Therapeutics presentation be available after the live event?

Yes, the webcast will be archived and available for 30 days following the presentation.

What is the stock symbol for PTC Therapeutics?

The stock symbol for PTC Therapeutics is PTCT.

Where can I find the PTC Therapeutics webcast?

The webcast can be found on the Events and Presentations page under the Investor section of PTC Therapeutics' website.

PTC Therapeutics, Inc.

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Stock Data

2.35B
76.70M
2.37%
113.55%
9.59%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
WARREN